Literature DB >> 6338821

Mechanisms of action of 5-fluorocytosine.

A R Waldorf, A Polak.   

Abstract

5-Fluorouracil and 5-fluorodeoxyuridine monophosphate levels were estimated in 75 isolates of Candida albicans to determine whether 5-fluorocytosine susceptibility could be ideally correlated with the intrafungal formation of both 5-fluorodeoxyuridine monophosphate and 5-fluorouridine triphosphate or a reciprocal formation of the two metabolites to prove the mechanism of 5-fluorocytosine activity. Using the results of four in vitro susceptibility tests, we separated isolates of C. albicans into susceptibility groups. For most strains, there was a positive correlation between the degree of 5-fluorocytosine susceptibility and the inhibition of biosynthesis of both RNA and DNA, incorporation of 5-fluorouracil into RNA, inhibition of ribosomal protein synthesis, and levels of 5-fluorodeoxyuridine monophosphate. However, in some strains with a similar degree of 5-fluorocytosine resistance, either reduced incorporation of 5-fluorouracil or reduced 5-fluorodeoxyuridine monophosphate levels occurred, suggesting that these two mechanisms are not necessarily linked to each other and that both may be responsible for 5-fluorocytosine activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338821      PMCID: PMC184621          DOI: 10.1128/AAC.23.1.79

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Mode of action of 5-fluorocytosine.

Authors:  R B Diasio; J E Bennett; C E Myers
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

2.  5-Fluorocytosine--current status with special references to mode of action and drug resistance.

Authors:  A Polak
Journal:  Contrib Microbiol Immunol       Date:  1977

3.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. I. Reversal experiments.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

4.  Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.

Authors:  A Polak; H J Scholer
Journal:  Pathol Microbiol (Basel)       Date:  1973

5.  Mode of action of 5-fluorocytosine and mechanisms of resistance.

Authors:  A Polak; H J Scholer
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

6.  The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.

Authors:  A Polak; W H Wain
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

7.  The effect of 5-fluorocytosine on the blastospores and hyphae of Candida albicans.

Authors:  A Polak; W H Wain
Journal:  J Med Microbiol       Date:  1979-02       Impact factor: 2.472

8.  Macromolecular syntheses during the cell cycles of yeast and hyphal phases of Candida albicans.

Authors:  W H Wain; M F Price; A R Brayton; R A Cawson
Journal:  J Gen Microbiol       Date:  1976-12

9.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  5-fluorocytosine resistance in Cryptococcus neoformans.

Authors:  E R Block; A E Jennings; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  32 in total

1.  Validation of 24-hour flucytosine MIC determination by comparison with 48-hour determination by the Clinical and Laboratory Standards Institute M27-A3 broth microdilution reference method.

Authors:  Shawn R Lockhart; Carol B Bolden; Naureen Iqbal; Randall J Kuykendall
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

2.  Study of the metabolism of flucytosine in Aspergillus species by 19F nuclear magnetic resonance spectroscopy.

Authors:  N Chouini-Lalanne; M C Malet-Martino; R Martino; G Michel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis.

Authors:  Annemarie E Brouwer; Hendrikus J M van Kan; Elizabeth Johnson; Adul Rajanuwong; Prapit Teparrukkul; Vannaporn Wuthiekanun; Wirongrong Chierakul; Nick Day; Thomas S Harrison
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

4.  Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types.

Authors:  Chris G Twitty; Oscar R Diago; Daniel J Hogan; Cindy Burrascano; Carlos E Ibanez; Douglas J Jolly; Derek Ostertag
Journal:  Hum Gene Ther Methods       Date:  2015-12-01       Impact factor: 2.396

5.  A novel screening system based on gene targeting to enrich the modified mammalian cells: without leaving selection marker and additional sequence.

Authors:  Abtin Behmardi; Majid Shahbazi; Masoud Golalipour; Touraj Farazmandfar
Journal:  3 Biotech       Date:  2019-09-05       Impact factor: 2.406

Review 6.  Persistence and drug tolerance in pathogenic yeast.

Authors:  Rasmus Bojsen; Birgitte Regenberg; Anders Folkesson
Journal:  Curr Genet       Date:  2016-05-19       Impact factor: 3.886

7.  A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.

Authors:  M Di Vito; F Podo; A Torosantucci; G Carpinelli; W L Whelan; D Kerridge; A Cassone
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

8.  Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.

Authors:  E Martin; F Maier; S Bhakdi
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

10.  19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.

Authors:  M O Fasoli; D Kerridge; P G Morris; A Torosantucci
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.